Last reviewed · How we verify
placebo intake
This drug has no known mechanism of action as it is a placebo.
This drug has no known mechanism of action as it is a placebo. Used for Treatment of symptoms in clinical trials.
At a glance
| Generic name | placebo intake |
|---|---|
| Sponsor | University Hospital, Rouen |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
A placebo is a dummy treatment that has no actual therapeutic effect. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Treatment of symptoms in clinical trials
Common side effects
- No adverse events
Key clinical trials
- IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes (PHASE3)
- A Study of HS-10518 in Healthy Adult Premenopausal Females in China (PHASE1)
- Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity (NA)
- Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder (PHASE2)
- Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI (NA)
- Exogenous Ketosis and Muscle Protein Synthesis During Exercise Recovery (NA)
- Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment (PHASE4)
- The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |